← SynDRA
PHYTONADIONE
SynDRA canonical compound SYN0009291 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | BGLAP | GGCX |
|---|
| Indication | anticoagulation reversal | vitamin K deficiency |
|---|
| Disease area | hematology |
|---|
All known targets
Mechanisms of action (all sources)
- F2 COFACTOR
- GGCX COFACTOR
Drug classes
- Antifibrinolytic Agents
- Coagulants
- Hematologic Agents
- Hemostatics
- Micronutrients
- Vitamins
- Warfarin Reversal Agent
- Vitamin K
ATC classes
- B02B · VITAMIN K AND OTHER HEMOSTATICS
Cross-references
Synonyms
- phytomenadione
- vitamin K1
- vitamin K
- phytylmenadione
- phytylmenaquinone
- phylloquinone
- Phytomenadione
- Fitomenadiona
- Phylloquinone e-form
- Vitamin k1
- NSC-270681
- Aquamephyton
- Kanavit
- Konakion
- Konakion mm
- Konakion mm paed
- Mephyton
- Neokay
- Orakay
- Phytonadione component of vitaped
- Vitamin k 1
- Phyllochinon
- Phyllohydroquinone
- Fitomenadione [DCIT]
- Phyllochinon [German]
- LT00452032
- Fitomenadiona [INN-Spanish]
- Mephyton (TN)
- Phylloquinone (8CI)
- Phytomenadione (INN)
- Phytomenadionum [INN-Latin]
- Phytonadione [USAN:JAN]
- Vitamin K1 (TN)
- Vitamin K1 (VAN)
- Vitamin K1 (generic)
- Phythyl-menadion (GERMAN)
- Phytonadione (JP15/USP)
- 1,4-Naphthalenedione, 2-methyl-3-((2E,7R,11R)-3,7,11,15-tetramethyl-2-hexadecenyl)-, radical ion(1-)
Reported adverse events
Look up PHYTONADIONE in the interactive SynDRA portal →